Innovasc Overview

  • Founded
  • 2007
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private

Innovasc General Information


Operator of a drug-research company intended to provide an alternative to stent technology. The company is developing drugs that permits minimal injury balloon angioplasty and minimal footprint tacking of blood vessel blockages, enabling patients to recover from injury and promote the natural healing of blood vessels.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Primary Office
  • 4644 Aukai Avenue
  • Honolulu, HI 96816
  • United States
+1 (808) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovasc Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 000.00 Completed Startup
5. Early Stage VC 08-Aug-2012 0000 000.00 Completed Startup
4. Early Stage VC (Series A) 00.00 00.000 Completed Startup
3. Early Stage VC 01-Dec-2010 00000 Completed Startup
2. Early Stage VC 01-Dec-2009 $250K Completed Startup
1. Early Stage VC 15-Nov-2008 $250K $250K Completed Startup
To view Innovasc’s complete valuation and funding history, request access »

Innovasc Executive Team (3)

Name Title Board Seat Contact Info
Peter Schnieder Co-Founder & Chief Executive Officer
Robert Giasoli Co-Founder
You’re viewing 2 of 3 executive team members. Get the full list »